Menu
Nano24 is a clinical-stage company developing the next generation of immunomodulators, using advanced nanotechnology; CD24-enriched exosomes, a futuristic better alternative to the common use of steroids, as a therapy for cytokine storm.
Acute respiratory distress syndrome (ARDS) is a non-cardiogenic pulmonary oedema and diffuse lung inflammation syndrome that often
complicates critical illness.
ARDS accounts for 20%-30% of ICU patients with 43% mortality
Exosomes - nano-sized lipid vesicles (30 to 200 nm)
CD24 - A small heavily glycosylated GPI-anchored protein functions as a novel immunomodulator
(Nature, 2019)
Clinically tested on more than 170 patients with mild or severe ARDS with two years of follow-up.
The right treatment at the right time, only to those in need...
A one fits all solution at the common junction
of the many medical conditions leading to ARDS.
Low manufacturing costs.
Easy to administrate and dramatically
reduces ICU admission rates
Strong IP
Proven safe and effective
Smarter than steroids
Production is efficient, rapid and at a low cost
Wide platform for numerous indications
Exponentially reduces burden on Health Systems
2022 © All rights reserved Nano Med | Wordpress Hosting: Fly Guy - https://fly-guy.club
